?? ioAstrocytes launch and exclusive CEO engagements.
Hi there,
This month, we're excited to highlight the early access launch of our ioAstrocytes! Dive into an exclusive interview with CEO Mark Kotter with Genetic Engineering & Biotechnology News, and The London Futurists Podcast discussing the future of biotech, and learn about the world's first CRISPR-ready cells available off-the-shelf.
Don't miss these updates and more in our June newsletter!
What's New?
Introducing ioAstrocytes | Advancing how scientists can model the human brain
bit.bio expands its ioCells portfolio with the launch of ioAstrocytes for scientists in CNS biology and drug discovery.
GEN interview with CEO Mark Kotter
Delve into this exclusive interview to learn about Mark Kotter’s journey from neurosurgery to bit.bio, the evolution of human iPSC research and the cell programming paradigm. Also, find out why bit.bio’s ioAstrocytes launch is so important for CNS research and drug discovery.
领英推荐
London Futurists Podcast with Mark Kotter
Don't miss this fascinating discussion on the future of food and medicine. Learn about the transformative potential of cultured meat, its benefits for people, animals, and the planet, as well as Mark’s journey within regenerative medicine.
Expert insights
A world first! Scientists can access functional hiPSC-derived CRISPR-ready cells off the shelf!
For the first time, our newly expanded opti-ox powered CRISPR-Ready ioCells toolkit gives you off-the-shelf access to functional human iPSC-derived microglia and glutamatergic neurons, built for the easy and routine generation of gene knockouts and CRISPR screens.?
Even if this is your first time using CRISPR or iPSC-derived cells, you can use CRISPR-Ready ioCells with our optimised protocols to start obtaining readouts in a matter of days. Everything is optimised for you.
Upcoming events
July 10 - 13
Hamburg | Germany
Connect with our team at ISSCR
Meet us at booth #1002 and discover the latest data at our eight poster presentations. Join our exciting lineup of insightful talks from leading experts in Alzheimer’s disease research, functional genomics, and an engaging panel discussion on standards for stem cells in non-clinical research.
Explore the full list of events we are attending here.
Editor-in-Chief Stem Cell Reviews and Reports at Springer
8 个月HIGH POWER!